News/ News/ R&D Amid crowded migraine market, Lundbeck goes its own way Phil Taylor CGRP, Lundbeck, migraine, PACAP, Vyepti 0 Comment The market for migraine treatment and prevention has been transformed by the launch of several new drugs targeting Share X Amid crowded migraine market, Lundbeck goes its own way https://pharmaphorum.com/news/amid-crowded-migraine-market-lundbeck-goes-its-own-way/
